Medicine and Dentistry
Assessment
14%
Ataxia
14%
Cerebellar Ataxia
28%
Cerebellum Degeneration
14%
Clinical Syndrome
14%
Combination Therapy
14%
Diagnosis
14%
Glia
57%
Granule Cell
57%
Infection
28%
Inpatient
14%
JC Virus
100%
Natalizumab
14%
Patient
28%
Polyomavirus Infection
14%
Progressive Multifocal Leukoencephalopathy
14%
Rituximab
42%
Viral Tropism
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ataxia
14%
Case Report
28%
Cerebellar Ataxia
28%
Cerebellum Degeneration
14%
Infection
28%
JC Virus
100%
Natalizumab
14%
Polyomavirus Infection
14%
Progressive Multifocal Leukoencephalopathy
14%
Rituximab
42%
Syndrome
14%
Neuroscience
Ataxia
42%
Granule Cell
57%
Natalizumab
14%
Progressive Multifocal Leukoencephalopathy
14%
Rituximab
42%
Tropism
14%
INIS
assessments
14%
mutations
14%
patients
42%
therapy
14%